Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin

Journal of Endocrinological Investigation

Volumn 30, Issue 7, 2007, Pages 535-540

  Rubio, I G S ^a   Silva, M N C ^a   Knobel, M ^a   Romao R ^a   Possato, R ^a   Gebrin, E M M S ^b   Buchpiguel, C ^b   Medeiros Neto, G ^a,b  

^a Division of Endocrinology   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Multinodular goiter; Radioiodine; Recombinant human thyroid stimulating hormone; Serum thyroglobulin; Thyroglobulin mRNA

Indexed keywords

IODINE 131; MESSENGER RNA; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROGLOBULIN ANTIBODY;

ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REDUCTION; FEMALE; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; NEEDLE BIOPSY; NODULAR GOITER; PREOPERATIVE CARE; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RADIOSURGERY; REAL TIME POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; THYROGLOBULIN BLOOD LEVEL; THYROID FOLLICLE CELL; THYROID WEIGHT;

EID: 35348918296     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346345     Document Type: Article

References (41)

1. Hegedus L, Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Enclocr Rev 2003, 24: 102-32.
2. Woodmansee WW, Haugen BR. Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter. Clin Endocrinol (Oxf) 2004, 61: 163-73.
3. Luster M, Lippi F, Jarzab B, et al. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review. Enclocr Relat Cancer 2005, 12: 49-64.
4. Huysmans DA, Nieuwlaat W, Erdtsieck J, et al. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodine uptake in nontoxic nodular goiter. J Clin Endocrinol and Metab 2000, 85: 3592-6.
5. Albino CC, Mesa CO Jr, Olandoski M, et al. Recombinant human thyrotropin as adjuvant in the treatment of multinoclular goiters with radioiodine. J Clin Endocrinol Metab 2005, 90: 2775-80.
6. Nieuwlaat WA, Hermus AR, Sivro-Prndelj F, Corstens FH, Huysmans DA. Pretreatment with recombinant human TSH changes the regional distribution on thyroid scintigrams of multinodular goiter. J Clin Endocrinol Metab 2001, 86: 5330-6.
7. 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial. J CIin Endocrinol Metab 2005, 90: 79-83.
8. Silva MN, Rubio IG, Romão R, et al. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goiters. Clin Endocrinol (Oxf) 2004, 60: 300-8.
9. Cohen O, Ilany J, Hoffman C, et al. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients. Eur J Endocrinol 2006, 154: 243-52.
10. Nielsen VE, Bonnema SJ, Boel-Joergensen H, Grupe P, Hegedus L. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial. Arch Intern Med 2006, 166: 1476-82.
11. Nieuwlaat WA, Huysmans DA, van den Bosch HC, et al. Pretreatment with a sinale, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter. J Clin Endocrinol Metab 2003, 88: 3121-9.
12. Ditkoff BA, Marvin MR, Yemul S, et al. Detection of circulating thyroid cells in peripheral blood. Surgery 1996, 120: 959-65.
13. Ringel MD, Ladenson PW, Levine ML. Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 1998, 83: 4435-42.
14. Tallini G, Ghossein RA, Emanuel J, et al. Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. J Clin Oncol 1998, 6: 1158-66.
15. Ringel MD, Balducci-Silano PL, Anderson JS, et al. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma. J Clin Endocrinol Metab 1999, 84: 4037-42.
16. Wingo ST, Ringel MD, Anderson JS, et al. Quantitative reverse transcription-PCR measurement of thyroglobulin mRNA in peripheral blood of healthy subjects. Clin Chem 1999, 45: 785-9.
17. Biscolla RP, Cerutti JM, Maciel RM. Detection of recurrent thyroid cancer by sensitive nested reverse transcription-polymerase chain reaction of thyroglobulin and sodium/iodide symporter messenger ribonucleic acid transcripts in peripheral blood. J Clin Endocrinol Metab 2000, 85: 3623-7.
18. Fenton C, Jeffrey AS, Patel A, et al. Thyroglobulin messenger ribonucleic acid levels in the peripheral blood of children with benign and malignant thyroid disease. Pediatr Res 2001, 49: 429-34.
19. Savagner F, Rodien P, Reynier P, Rohmer V, Bigorgne JC, Malthiery Y. Analysis of Tg transcripts by real-time RT-PCR in the blood of thyroid cancer patients. J Clin Endocrinol Metab 2002, 87: 635-9.
20. Chinnappa P, Taguba L, Arciaga R. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin m RNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer. J Clin Endocrinol Metab 2004, 89: 3705-9.
21. Barzon L, Boscaro M, Pacenti M, Taccaliti A, Palu G. Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse. Int J Cancer 2004, 110:914-20.
22. Li D, Butt A, Clarke S, Swaminathana R. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects. Ann N Y Acad Sci 2004, 1022: 147-51.
23. Eszlinger M, Neumann S, Otto L, Paschke R. Thyroglobulin mRNA quantification in the peripheral blood is not a reliable marker for the follow-up of patients with differentiated thyroid cancer. Eur J Endocrinol 2002, 147: 575-82.
24. Takano T, Miyauchi A, Yoshida H, Hasegawa Y, Kuma K, Amino N. Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy. Br J Cancer 2001, 85: 102-6.
25. Bugalho MJ, Domingues RS, Pinto AC, et al. Detection of thyroglobulin mRNA transcripts in peripheral blood of individuals with and without thyroid glands: evidence for thyroglobulin expression by blood cells. Eur J Endocrinol 2001, 145: 409-13.
26. Span PN, Sleegers MJ, van den Broek WJ, et al. Quantitative detection of peripheral thyroglobulin mRNA has limited clinical value in the follow-up of thyroid cancer patients. Ann Clin Biochem 2003, 40: 94-9.
27. Denizot A, Delfino C, Dutour-Meyer A, Fina F, Ouafik L. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer. Thyroid 2003, 13: 867-72.
28. Grammatopoulos D, Elliott Y, Smith SC, et al. Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer. Mol Pathol 2003, 56: 162-6.
29. Elisei R, Vivaldi A, Agate L, et al. Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients. J Clin Endocrinol Metab 2004, 89: 33-9.
30. Kaufmann S, Schmutzler C, Schomburg L, et al. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin. Endocr Regul 2004, 38: 41-9.
31. Bojunga J, Zeuzem S. Molecular detection of thyroid cancer: an update. Clin Endocrinol (Oxf) 2004, 61: 523-30.
32. Ringel MD. Molecular detection of thyroid cancer: differentiating "signal" and "noise" in clinical assays. J Clin Endocrinol Metab 2004, 89: 29-32.
33. Ramirez L,.Sraverman LE, White B, Emerson CH. Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects. J Clin Endocrinol Metab 1997, 82: 2836-9.
34. Torres MS, Ramirez L, Simkin PH, Braverman LE, Emerson CH. Effect of various doses of recombinant human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. J Clin Endocrinol Metab 2001, 86: 1660-4.
35. Nielsen VE, Bonnema SJ, Hegedüs L. The effects of recombinant human thyrotropin, in normal subjects and patients with goitre. Clin Endocrinol 2004, 61: 655-63.
36. Nielsen VE, Bonnema SJ, Hegedüs L. Effects of 0.9 mg recombinant human thyrotropin on thyroid size and function in normal subjects: a randomized, double-blind, cross-over trial. J Clin Endocrinol Metab 2004, 89: 2242-7.
37. Rublo IG, Perone BH, Silva MN, Knobel M, Medeiros-Neto G. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies. Thyroid 2005, 15: 134-9.
38. Duick DS, Baskin HJ. Significance of radioiodine uptake at 72 hours versus 24 hours after pretreatment with recombinant human thyrotropin for enhancement of radioiodine therapy in patients with symptomatic nontoxic or toxic multinodular goiter. Endocr Pract 2004, 10: 253-60.
39. Nieuwlaat WA, Hermus AR, Ross HA, et al. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroidstimulating hormone. J Nucl Med 2004, 45: 626-33.
40. Nielsen VE, Bonnema SJ, Hegedüs L. Transient goiter enlargement after administration of 0.3 mg recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, cross-over trial. J Clin Endocrin Metab 2006, 9: 1317-22.
41. Robbins RJ, Voelker E, Wang W, Macapinlac HA, Larson SM. Compassionate use of recombinant human thyrotropin to facilitate radioiodine therapy: case report and reviews of literature. Endocr Pract 2000, 6: 460-4.